HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparison of isosorbide dinitrate and nifedipine in the treatment of variant angina pectoris. Randomized study].

Abstract
The effects of isosorbide dinitrate single dose 120 mg daily and nifedipine 20 mg twice daily were studied in 17 patients with variant angina pectoris due to coronary artery spasm. After a placebo phase the patients were randomized to treatment with either isosorbide dinitrate or nifedipine. After six weeks the patients were crossovered for another six weeks period of treatment. There was significant decrease of number of angina attacks during both treatment regimens. Using 24 hours Holter monitoring we also proved significant decrease of number of ST segment elevation or depression, either symptomatic or asymptomatic. There was increase of performed work during exercise tests after both treatment periods. The efficacy of Isoket 120 mg and Adalat Retard 2 x 20 mg daily in the treatment of patients with active variant angina pectoris was comparable in our study. 3 patients suffered untolerable headache during isosorbide dinitrate phase and had to terminate treatment after first day only.
AuthorsM Aschermann, J Bultas, D Karetová, F Kölbel, D Simper, M Kozáková
JournalCasopis lekaru ceskych (Cas Lek Cesk) Vol. 128 Issue 37 Pg. 1178-81 (Sep 08 1989) ISSN: 0008-7335 [Print] Czech Republic
Vernacular TitleSrovnání isosorbid dinitrátu a nifedipinu v lécbĕ variantní anginy pectoris. Randomizovaná studie.
PMID2805034 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nifedipine
  • Isosorbide Dinitrate
Topics
  • Adult
  • Angina Pectoris, Variant (drug therapy, physiopathology)
  • Double-Blind Method
  • Electrocardiography, Ambulatory
  • Female
  • Humans
  • Isosorbide Dinitrate (therapeutic use)
  • Male
  • Middle Aged
  • Nifedipine (therapeutic use)
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: